Global Epilepsy Monitoring Devices Market, By Product Type (Conventional and Wearable Devices, Deep Brain Stimulation Devices, Ambulatory EEG Device, Others), By End User (Hospitals, Diagnostic Centers, Specialty Clinics, Others), and Geography (North Ame
Global Epilepsy Monitoring Devices Market, By Product Type (Conventional and Wearable Devices, Deep Brain Stimulation Devices, Ambulatory EEG Device, Others), By End User (Hospitals, Diagnostic Centers, Specialty Clinics, Others), and Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Global epilepsy monitoring devices market is witnessing significant growth due to rising prevalence of epilepsy disorders worldwide. Epilepsy is a chronic non-communicable disease characterized by recurrent seizures that affect people of all ages. However, it is more common in children and older adults. Epilepsy occurs due to disturbances in the electrical activity of the brain. Epilepsy monitoring devices help physicians and neurologists in monitoring epileptic seizures by analyzing brain waves through electroencephalography (EEG). Devices like video-EEG systems and ambulatory EEG systems are widely used for prolonged monitoring of epilepsy patients, especially whose seizures are difficult to capture or diagnose. Advancements in EEG technology and availability of portable ambulatory epilepsy monitors have boosted the adoption of epilepsy monitoring devices.
Market Dynamics:
Global epilepsy monitoring devices market growth is driven by rising geriatric population susceptible to epilepsy, growing awareness about epilepsy disorders, increasing research funding for epilepsy, and favorable reimbursement policies. However, high costs associated with EEG monitoring and ambulatory epilepsy monitoring devices hampers the market growth. Furthermore, ongoing R&D in precision diagnostics and development of next-generation portable epilepsy monitors present significant opportunities for the market growth. Growing demand for non-invasive and long-term ambulatory monitoring also offer significant opportunities for the market growth. Stringent regulatory approvals for new product launches and lack of skilled neurology professionals pose challenges for the market growth.
Key Features of the Study:
This report provides in-depth analysis of the global epilepsy monitoring devices market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global epilepsy monitoring devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study Boston Scientific Corporation, Compumedics Limited, Drägerwerk AG & Co. KGaA, Empatica Inc., Lifelines Neuro, Natus Medical Incorporated, Magstim, Nihon Kohden Corporation, Masimo, Medtronic, Mitsar Co. LTD., Seer Medical, EMOTIV, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Cadwell Industries, Inc., Ceribell, Inc., Neuraxpharm.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global epilepsy monitoring devices market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global epilepsy monitoring devices market.